Peng Tzu-Chiang, Lin Chun-Fu, Kuan Ai Seon, Wu Hsiu-Mei, Lee Cheng-Chia, Lin Chung-Jung, Yang Huai-Che
Department of Neurosurgery, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan.
Department of Radiology, Taipei Veterans General Hospital, Taipei, Taiwan.
Acta Neurochir (Wien). 2025 Apr 29;167(1):123. doi: 10.1007/s00701-025-06536-1.
Stereotactic radiosurgery (SRS) is widely used for the treatment of intracranial dural arteriovenous fistulas (DAVFs); however, the outcomes of repeated SRS to deal with residual DAVFs are unclear. This study assessed the benefits and potential negative consequences of repeated SRS in patients with residual DAVFs.
This retrospective study examined all patients who underwent two SRS procedures for DAVFs in a single academic medical center between January 1998 and December 2022. Information related to patient demography, DAVFs characteristics, and clinical outcomes were obtained from medical records. The objective in this study was to obtain a preliminary overview of the results of repeated SRS for DAVFs.
The study cohort of 19 patients included 14 patients with non-cavernous sinus (NCS) DAVFs and 5 patients with cavernous sinus (CS) DAVFs. The NCS group included 8 patients who were categorized as low-grade (Borden grade 1) and 6 as high-grade (Borden grade 2 or 3). The median follow up duration after the second session of SRS was 37 months. Symptomatic improvement was noted in 16 patients (84.2%) and total obliteration was identified in 11 patients (57.9%). No patient suffered from intracranial hemorrhage after the repeated SRS. One patient (5.3%) experienced symptomatic radiation-induced change mandating temporary course of medical treatment.
Repeated SRS appears to be a safe and effective approach to deal with residual DAVFs, resulting in symptomatic improvement and complete radiologic obliteration.
立体定向放射外科(SRS)广泛应用于颅内硬脑膜动静脉瘘(DAVF)的治疗;然而,重复进行SRS治疗残留DAVF的效果尚不清楚。本研究评估了重复SRS治疗残留DAVF患者的益处和潜在不良后果。
这项回顾性研究检查了1998年1月至2022年12月期间在单一学术医学中心接受两次DAVF的SRS治疗的所有患者。从病历中获取了与患者人口统计学、DAVF特征和临床结果相关的信息。本研究的目的是初步概述重复SRS治疗DAVF的结果。
19例患者的研究队列包括14例非海绵窦(NCS)DAVF患者和5例海绵窦(CS)DAVF患者。NCS组包括8例低级别(Borden 1级)患者和6例高级别(Borden 2级或3级)患者。第二次SRS治疗后的中位随访时间为37个月。16例患者(84.2%)症状改善,11例患者(57.9%)完全闭塞。重复SRS治疗后无患者发生颅内出血。1例患者(5.3%)出现有症状的放射性改变,需要进行临时治疗。
重复SRS似乎是治疗残留DAVF的一种安全有效的方法,可改善症状并实现影像学完全闭塞。